The Latest Recommendations for Healthy Heart

October 5, 2023 / BY / IN Blog, Posts

IV Infusion Therapy at Pathway Health & Wellness for Optimal Health


Decrease blood pressure + Optimize cardiovascular function

Taurine l Zinc l Biotin l Magnesium l Pyridoxine l Calcium l L-Arginine

  • WEIGHT LOSS $160  

Burn Fat + Boost Metabolism + Enhance Blood flow & Circulation

MethylcobalamIn I Glutamine I B Complex l Pyridoxine l Ascorbic Acid l Glutathione l Alpha Lipoic Acid  l Lipo-C


Optimal blood glucose level + Reduce neuropathy + Maximize kidney function

Glutamine l Taurine l Zinc l Biotin l Alpha Lipoic Acid


Weight Loss Therapy at Pathway Health Service

  • Reset your Metabolism with TRME – $750 for the metabolic reset package
  • Semaglutide – Weekly injection along with B12
  • Weight Loss IV Infusion Therapy $160

The Latest Recommendations for Healthy Heart

  • According to 2023 American College of Cardiology/American Heart Association Guideline, routine stress testing in patients with stable coronary disease is no longer recommended.
  • Skolnik stated that diet and exercise are critical, are underappreciated, and make a huge difference to your cardiovascular health.
        • on and physical activity — This is critically important.
          • Mediterranean-style dietary plans can lead to a 65% reduction in composite cardiovascular outcomes like cardiac death and recurrent MI.
          • Higher-quality carbohydrate intake, which means cutting down on highly processed carbohydrates, leads to lower cardiovascular morbidity and mortality, as does lower saturated fat intake.
          • Physical activity — the goal being 150-300 minutes a week of moderate to vigorous aerobic activity, however, smaller amounts of activity are helpful as well, so keep moving.
          • Resistance training (strength training exercises) should be done 2 or more days a week and reduce the amount of time spent in sedentary activities.
          • Mental health is also important. Depression and anxiety diminish quality of life and lead to worse cardiovascular outcomes.
        • The LDL cholesterol goal is < 70 mg/dL and the blood pressure target is < 130/80 mm Hg
        • Importance of weight management.
          • glucagon-like peptide 1 (GLP-1) receptor agonists and sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk for major adverse cardiovascular events (MACEs). Weight management is important. Excess weight accelerates atherosclerotic formation.
          • The guidelines say it’s reasonable to choose semaglutide over liraglutide because of its greater efficacy. Recent studies have indicated that semaglutide decreased MACEs in people with chronic coronary disease and obesity. For patients with diabetes, use a GLP-1 receptor agonist or an SGLT2 inhibitor to reduce cardiovascular events.


    Neil Skolnik, MD. (September 12, 2023). Chronic Coronary Disease: The Latest Recommendations. Copied from Chronic Coronary Disease: The Latest Recommendations (